Pros | ![]() Larger AUM within category. | ![]() 3Y returns in the top 25% of the category. ![]() Larger AUM within category. ![]() Beats FD returns for both 3Y & 5Y duration. | ||
Cons | - | - |
INDMoney rank | - | 7/23 | ||
Category,Subcateogry | Equity,Global - Other | Equity,Global - Other | ||
Fund Age | 4 Years | 12 Years | ||
Fund Size | 2925 Cr | 3019 Cr | ||
Min Investment | SIP ₹1000 Lumpsum ₹100 | SIP ₹100 Lumpsum ₹5000 | ||
Expense Ratio | 0.25% | 1.25% | ||
Exit Load | 0% | 1% | ||
Benchmark Index | NASDAQ 100 TR INR | S&P 500 TR USD |
No of Holdings | - | 64 | ||
Top 5 Holdings | - | Gilead Sciences Inc (3.19%) Altria Group Inc (2.91%) The Walt Disney Co (2.85%) Bristol-Myers Squibb Co (2.8%) Corteva Inc (2.79%) | ||
No of Sectors | - | 9 | ||
Top 3 Sectors | - | Health (26.54%) Consumer Defensive (15.61%) Industrial (15.56%) | ||
Equity % | - | 98.08% | ||
Debt % | - | - | ||
P/E | 30.17 | 23.71 | ||
P/B | 7.02 | 3.23 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -10.92% | -9.49% | ||
3-Month Return | -15.35% | -9.19% | ||
6-Month Return | -8.49% | -12.37% | ||
1-Year Return | 1.88% | -3.2% | ||
3-Year Return | 12.26% | 8.46% | ||
5-Year Return | - | 13.48% |
Sharpe | 0.39 | 0.25 | ||
Alpha | - | -3.29 | ||
Beta | - | 1.04 | ||
Standard Deviation | 20.03 | 18.84 | ||
Information Ratio | - | -0.48 |
Description | Kotak NASDAQ 100 Fund of Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ICICI Prudential US Bluechip Equity Fund Direct Plan Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Arjun Khanna,Abhishek Bisen | Ritesh Lunawat |